Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
PaperCitations, authors & open-access status
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,157 citations, 2017 year and closed oa status.
1,157
Citations
2017
Year
closed
OA Status